000 | 02014 a2200517 4500 | ||
---|---|---|---|
005 | 20250515002355.0 | ||
264 | 0 | _c20051102 | |
008 | 200511s 0 0 eng d | ||
022 | _a0732-183X | ||
024 | 7 |
_a10.1200/JCO.2005.11.411 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPession, Andrea | |
245 | 0 | 0 |
_aLong-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia. _h[electronic resource] |
260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cOct 2005 |
||
300 |
_a7161-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aAsparaginase _xadministration & dosage |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aValsecchi, Maria Grazia | |
700 | 1 | _aMasera, Giuseppe | |
700 | 1 | _aKamps, Willem A | |
700 | 1 | _aMagyarosy, Edina | |
700 | 1 | _aRizzari, Carmelo | |
700 | 1 | _avan Wering, Elisabeth R | |
700 | 1 | _aLo Nigro, Luca | |
700 | 1 | _avan der Does, Anna | |
700 | 1 | _aLocatelli, Franco | |
700 | 1 | _aBasso, Giuseppe | |
700 | 1 | _aAricò, Maurizio | |
773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 23 _gno. 28 _gp. 7161-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2005.11.411 _zAvailable from publisher's website |
999 |
_c15823340 _d15823340 |